Tradestie Institutional Equity Comparison Engine

PACB vs BMRA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BMRA Overall Edge

BMRA Captures Institutional Edge (2โ€“1 Pillars ยท 4โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Biomerica Inc (BMRA) driven by superior Growth & Margin, Options & Structure while PACB counters with relative strength in Momentum & Technical. Fundamentally, PACB trades at N/M Forward P/E with -333.0% operating margin (+5.5% YoY revenue) versus BMRA at N/M Forward P/E and -125.2% operating margin (-8.3% YoY). In options structure, PACB sits in BREAKDOWN (47th %ile IV; Dealer Gamma Walls on Pro) against BMRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
PACB N/M vs BMRA N/M Fwd P/E
Growth & Margin Winner BMRA
Op Margin -333.0% vs -125.2% ยท YoY +5.5% vs -8.3%
Momentum & Technical Winner PACB
1Y +15.0% vs -46.9% ยท 52W Pos 34% vs 4%
Options & Structure Winner BMRA
BREAKDOWN (47th %ile IV) vs UNCLASSIFIED (N/A IV)
PACB NASDAQ
Pacific Biosciences of California, Inc.
Laboratory Analytical Instruments
$1.88
-4.34% 1D
Market Cap $615.1M
1M Return +8.38%
1Y Return +15.03%
Forward P/E N/M
Unified AI Score
42.0 / 100 HOLD
Tech 15.0 Fund 36.0 Flow 57.0 Mom 40.0
BMRA NASDAQ
Biomerica Inc
In Vitro & In Vivo Diagnostic Substances
$1.33
-2.32% 1D
Market Cap $6.0M
1M Return -28.19%
1Y Return -46.86%
Forward P/E N/M
Unified AI Score
44.5 / 100 HOLD
Tech 40.0 Fund 47.0 Flow 50.0 Mom 44.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PACB +15.03% BMRA -46.86% Spread: +61.89 pp (PACB Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period PACB Revenue BMRA Revenue PACB Op. Margin BMRA Op. Margin Margin Edge
FY2019 $90M $10M -110.6% -46.4% BMRA
FY2020 $80M $10M -132.3% -41.0% BMRA
FY2021 $130M $10M -161.2% -104.2% BMRA
FY2022 $130M $20M -239.4% -24.0% BMRA
FY2023 $200M $10M -166.8% -135.3% BMRA
FY2024 $150M $10M -308.0% -117.6% BMRA
FY2025 $160M $10M -346.2% -96.7% BMRA
FY2026 N/A $0M N/A -119.5% BMRA

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PACB (4) vs BMRA (4)
Institutional Metric PACB BMRA Criterion Row Winner
Market Capitalization Scale $615.1M $6.0M Larger Scale PACB
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +5.5% -8.3% Higher Growth PACB
Operating Margin (TTM) Profitability -333.0% -125.2% Higher Margin BMRA
Net Profit Margin Profitability -81.3% -115.5% Higher Margin PACB
Return on Equity (ROE) Capital Efficiency -929.3% -113.8% Higher ROE BMRA
52-Week Range Position Momentum 34% ($1โ€“$3) 4% ($1โ€“$3) Stronger Trend PACB
Beta / 30D Volatility Risk Regime 2.24ฮฒ ยท 110% Vol 0.67ฮฒ ยท 62% Vol Lower Realized Risk BMRA
Unified Institutional Score Composite Signal 42.0 / 100 (HOLD) 44.5 / 100 (HOLD) Higher Composite BMRA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PACB vs BMRA Buy Guide
PACB BREAKDOWN
12d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 47th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live PACB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BMRA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BMRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PACB nor BMRA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.